⌕
DaVita · DVA · NYSE
Tenet — · insufficient data
Compare
$174.22−0.19%At close
$174.22−0.34 (−0.19%)
At close: Nov 16, 2026, 4:00 PM ET· NYSE · USD
Data under review. Our nightly checks found a problem in this company's reported figures on Oct 23, 2026, so we are not showing its score, ratios or statements for now. The figures come back after they pass the checks two nights in a row. The price and chart are live.

DaVita (DVA) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

● MarketBeatNov 13, 2026 · 03:14 ETEARNINGS EXPECTED BY FEB 11
DaVita Expects Fewer Dialysis Treatments in Q4, but Higher Revenue per Visit Could Help Offset the Drop

DaVita NYSE: DVA expects a meaningful sequential decline in dialysis treatments in the fourth quarter because of calendar effects, but higher revenue per treatment should help offset the impact, Chief Financial Officer J…

● Business WireNov 12, 2026 · 13:46 ET
DVA Investors Have Opportunity to Join DaVita Inc. Fraud Investigation with SBS Law

LOS ANGELES--(BUSINESS WIRE)---- $DVA--DVA Investors Have Opportunity to Join DaVita Inc. Fraud Investigation with SBS Law.…

● BenzingaNov 12, 2026 · 12:15 ET
Dialysis Giants DaVita and Fresenius Blocking Competition In Washington, Lawsuit Accuses

Washington Attorney General Nick Brown on Tuesday filed a lawsuit accusing the state's two largest for-profit dialysis providers of imposing illegal noncompete agreements on medical directors, blocking competition and re…

● PRNewsWireNov 12, 2026 · 11:25 ET
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DaVita Inc. - DVA

NEW YORK, Nov. 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of DaVita Inc. ("DaVita" or the "Company") (NYSE: DVA).  Such investors are advised to contact Danielle Peyton at newac…

● Defense WorldNov 12, 2026 · 04:13 ET
DaVita (NYSE:DVA) Shares Cross Above 200 Day Moving Average – What’s Next?

DaVita Inc. (NYSE: DVA - Get Free Report) shares passed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $179.73 and traded as high as $183.50. DaVita shares last tr…

● Zacks Investment ResearchNov 11, 2026 · 17:21 ET
DaVita HealthCare (DVA) is a Top-Ranked Value Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.…

● Seeking AlphaNov 10, 2026 · 11:01 ET
DaVita Inc. (DVA) Presents at 8th Annual Wolfe Research Healthcare Conference Transcript

DaVita Inc. (DVA) Presents at 8th Annual Wolfe Research Healthcare Conference Transcript…

● MarketBeatNov 10, 2026 · 05:12 ET
DaVita Sees Growth and Drug Savings Offsetting 2027 Reimbursement Pressure

DaVita NYSE: DVA expects stronger dialysis treatment growth and pharmaceutical cost savings to help offset reimbursement pressures in 2027, though Chief Financial Officer Joel Ackerman said changes in patients' insurance…

● GlobeNewsWireNov 9, 2026 · 18:00 ET
Lowey Dannenberg, P.C. is Investigating DaVita Inc. (NYSE: DVA) for Potential Violations of the Federal Securities Laws

NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating DaVita Inc. (NYSE: DVA) (“DaVita” or the “Company”) for potentia…

● Seeking AlphaNov 9, 2026 · 16:01 ET
DaVita Inc. (DVA) Presents at 2026 UBS Global Healthcare Conference Transcript

DaVita Inc. (DVA) Presents at 2026 UBS Global Healthcare Conference Transcript…

● PRNewsWireNov 5, 2026 · 19:42 ET
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DaVita Inc. - DVA

NEW YORK, Nov. 5, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of DaVita Inc. ("DaVita" or the "Company") (NYSE: DVA).  Such investors are advised to contact Danielle Peyton at newact…

● Zacks Investment ResearchNov 5, 2026 · 10:01 ET
Investors Heavily Search DaVita Inc. (DVA): Here is What You Need to Know

DaVita HealthCare (DVA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.…

● Business WireNov 4, 2026 · 09:00 ET
Did You Lose Money on DaVita Inc. Stock? The Law Offices of Howard G.

BENSALEM, Pa.--(BUSINESS WIRE)--Investors who suffered losses on DaVita Inc. ("DaVita" or the "Company") stock may have claims to recover those losses. The Law Offices of Howard G. Smith today reported that it is conduct…

● PRNewsWireNov 3, 2026 · 16:05 ETCOMPANY'S OWN WORDS
DaVita Inc. to Participate in Upcoming Investor Conferences

DENVER, Nov. 3, 2026 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its Chief Financial Officer, Joel Ackerman, and its Group Vice President of Investor Relations, Nic Eliason, will participate in fireside …

● Business WireNov 3, 2026 · 13:50 ET
Lost Money on DaVita Inc. Shares? The Law Offices of Frank R.

LOS ANGELES--(BUSINESS WIRE)--DaVita Inc. ("DaVita" or the "Company") investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz today announced it is investigating potential secur…

● Zacks Investment ResearchOct 30, 2026 · 12:01 ETEARNINGS EXPECTED BY FEB 11
DaVita Q3 Earnings Beat Estimates on IKC Strength, Revenues Rise Y/Y

DVA's Q3 earnings surge 52.2% as revenues rise 4.6%, fueled by strong kidney care and international growth despite rising costs and margin pressure.…

● MarketBeatOct 30, 2026 · 06:14 ETEARNINGS EXPECTED BY FEB 11
What DaVita (DVA) Said on Its Q3 Earnings Call

DaVita NYSE: DVA reported third-quarter adjusted operating income of $561 million, adjusted earnings per share of $3.82 and free cash flow of $276 million, while narrowing its full-year 2026 outlook. The kidney-care prov…

● Seeking AlphaOct 29, 2026 · 20:38 ETEARNINGS EXPECTED BY FEB 11
DaVita Inc. (DVA) Q3 2026 Earnings Call Transcript

DaVita Inc. (DVA) Q3 2026 Earnings Call Transcript…

● Zacks Investment ResearchOct 29, 2026 · 18:36 ETEARNINGS EXPECTED BY FEB 11
DaVita HealthCare (DVA) Beats Q3 Earnings and Revenue Estimates

DaVita HealthCare (DVA) came out with quarterly earnings of $3.82 per share, beating the Zacks Consensus Estimate of $3.78 per share. This compares to earnings of $2.51 per share a year ago.…

● BenzingaOct 29, 2026 · 17:56 ETEARNINGS EXPECTED BY FEB 11
DaVita Q3 2026 Earnings Call Transcript

DaVita (NYSE:DVA) reported third-quarter financial results on Thursday. The transcript from the company's third-quarter earnings call has been provided below.…

● PRNewsWireOct 29, 2026 · 16:05 ETCOMPANY'S OWN WORDSEARNINGS EXPECTED BY FEB 11
DaVita Inc. 3rd Quarter 2026 Results

DENVER, Oct. 29, 2026 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2026. Financial and operating highlights for the quarter ended September 30, 202…

● PRNewsWireOct 29, 2026 · 09:20 ET
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DaVita Inc. - DVA

NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of DaVita Inc. ("DaVita" or the "Company") (NYSE: DVA).  Such investors are advised to contact Danielle Peyton at newac…

PRNewsWire · Oct 29, 2026

Kept in their own lane. A press release is the company talking, not reporting.

Expected by Feb 11. Report dates come from the data provider's upcoming-earnings feed and are its estimate, not a date the company has set.

Quiet tape today.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.